4//SEC Filing
Clark David J 4
Accession 0000899243-19-023265
CIK 0001341235other
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 5:01 PM ET
Size
5.4 KB
Accession
0000899243-19-023265
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Purchase
Common Stock
2019-09-06$5.06/sh+5,000$25,311→ 17,878 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes 1,366 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001662693
Filing Metadata
- Form type
- 4
- Filed
- Sep 9, 8:00 PM ET
- Accepted
- Sep 10, 5:01 PM ET
- Size
- 5.4 KB